FDA Approves COVID-19 Trial After Successful Umbilical Stem Cell Research
RESTEM, a leading cell-based therapeutics company, announced today it has received approval from the U.S. Food and Drug Administration (FDA) for a [...]
Dr. Rafael Gonzalez
